모아라이프플러스

142760KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

587KRWMarket close of 10/20 (Tue)

Up +0.51%+3KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)516KRWDown -12.10%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open: 581
High: 675
Low: 553
Day range: Day range low 553 high 675, open 581, close 587, previous close 584
Volume: 252×10K shares
: 1.6B KRW 3.40× the 20-session average

Market close of 10/20 (Tue)

Something to check

2 to check: more trading value than usual · operating loss

Free · no sign-inSource from 2021-05-17

Points to check

Trading valueto check3.4×1.6B KRW, 3.4× the 20-session average
3.40× the 20-session average · check threshold 3×
Earningsto check-6.8B KRWOperating income over the last four quarters -6.8B KRW (loss)Operating income, 8 quarters
Recent filingsnot verifiedOutside filing data coverage, so not verified

The other 3

Foreign & institutionalnot verified
Daily move+0.51%usual range
Data date10/20 (Tue)Market close

See the full check report

Key figures

: 12.4B KRW
: Not computed — loss-making, or the four quarters are incomplete
: 0.39×
: 21,083,490 shares
Trading value ratio: 3.40× the 20-session average3.4×

Financials filed 2026-05-15 · KRX·DART

Something to check

2 to check: more trading value than usual · operating loss

Trading valueto check3.40× the 20-session average3.4×1.6B KRW, 3.4× the 20-session average
Earningsto checkQuarterly operating income bars (6); the four dark bars make up the sum-6.8B KRW
Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
Daily moveusual range+0.51% on the reference date, placed against the usual ±3.21% band0.2×
Data dateusual rangeMarket close data of 2026-10-20

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected

Revenue2.3B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
-24.7%
vs. prior quarter
-49.5%
Operating income-1.4B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
Still a loss
vs. prior quarter
Still a loss
Operating margin-58.2%Operating margin bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
-23.5 pp
vs. prior quarter
+2.5 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15

2021Q1 -2.0B KRW2026Q1 -1.4B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 바이오 R&D

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock	20D	Change	Trading value
알테오젠	Close over the last 20 sessions -9.6%	Down -3.35%	51.1B KRW
올릭스	Close over the last 20 sessions -12.2%	Down -4.03%	19.1B KRW
디앤디파마텍	Close over the last 20 sessions -11.8%	Down -1.93%	15.1B KRW
리가켐바이오	Close over the last 20 sessions -15.4%	Down -1.41%	12.1B KRW
프로티나	Close over the last 20 sessions +31.8%	Up +7.38%	10.0B KRW

Schedule

Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.